Case Report
Accepted on 31 Oct 2024
Satralizumab therapy for bilateral refractory optic neuritis following the first dose of bivalent human papilloma virus vaccine
in Vaccines and Molecular Therapeutics
Case Report
Accepted on 31 Oct 2024
in Vaccines and Molecular Therapeutics
Editorial
Accepted on 31 Oct 2024
in Brain Imaging Methods
Original Research
Accepted on 31 Oct 2024
in Smart Technologies
Study Protocol
Accepted on 31 Oct 2024
in Neurorehabilitation
Correction
Accepted on 31 Oct 2024
in Children and Health
Original Research
Accepted on 31 Oct 2024
in Pediatric Otolaryngology
Original Research
Accepted on 31 Oct 2024
in Coastal and Offshore Engineering
Review
Accepted on 31 Oct 2024
in Nutrition, Psychology and Brain Health
Mini Review
Accepted on 31 Oct 2024
in Connected Health
Original Research
Accepted on 31 Oct 2024
in Archaeological Isotope Analysis
Systematic Review
Accepted on 31 Oct 2024
in Obstetrics and Gynecology
Original Research
Accepted on 31 Oct 2024
in Models in Ecology and Evolution
Original Research
Accepted on 31 Oct 2024
in Quaternary Science, Geomorphology and Paleoenvironment
Original Research
Accepted on 31 Oct 2024
in Molecular Viral Pathogenesis
Original Research
Accepted on 31 Oct 2024
in Ethnopharmacology
Review
Accepted on 31 Oct 2024
in Cellular Neuropathology